drugset / Trial / NCT00666354

Dose Response and Safety Study of Topical Methotrexate for the Treatment of Fingernail Psoriasis

NCT00666354 ↗

Phase 2 Unknown 83 enrolled MediQuest Therapeutics
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this clinical study is to compare the efficacy and safety of three concentrations of topical methotrexate for the treatment of fingernail psoriasis.

Timeline

Start
2007-10
Primary completion
2008-09
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methotrexate Small molecule 0.05 % Topical
Comparator Methotrexate Small molecule 0.25 % Topical
Comparator Methotrexate Small molecule 1 % Topical

Indications